Breaking Down Patanjali Foods Limited Financial Health: Key Insights for Investors

Breaking Down Patanjali Foods Limited Financial Health: Key Insights for Investors

IN | Consumer Defensive | Packaged Foods | NSE

Patanjali Foods Limited (PATANJALI.NS) Bundle

Get Full Bundle:
$25 $15
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7

TOTAL:

Dive into a data-driven look at Patanjali Foods Limited's latest financials: Q3FY25 standalone revenue surged to ₹9,103.13 crore (up 48.79% YoY) propelling nine‑month revenue to ₹24,430.38 crore, while the Edible Oil segment delivered ₹6,764.07 crore in Q4FY25 sales and the Food/FMCG/HPC mix contributed 30.61% of operational revenue; profitability improved with EBITDA of ₹581.24 crore (EBITDA margin 6.39%) and Q3 net profit at ₹370.93 crore (net margin 4.06%), alongside a 254 bps jump in gross margin to 17.00% in Q4FY25; balance sheet strength is notable - debt-free long-term capital structure, net worth up 10.4% to ₹11,255 crore, total assets at ₹15,420 crore (up 17% YoY), current ratio 2.29 and quick ratio 1.85 - while valuation shows market cap of ₹58,400 crore with a TTM P/E of 40.89 (forward P/E 35.93), EPS ₹13.13 and analysts' 12‑month average target of ₹2,000 (implying ~236.76% upside); juxtapose these figures with rising A&P spend (₹233.36 crore in FY25), edible oil price volatility, HPC integration risks, and emerging growth levers like international exports (₹73.44 crore in Q4FY25), nutraceutical sales (₹19.42 crore quarterly) and 87,109 hectares of oil palm plantations to assess the investment case further

Patanjali Foods Limited (PATANJALI.NS) - Revenue Analysis

Patanjali Foods Limited delivered strong top-line momentum in recent quarters, driven by core edible oil volumes and an expanding presence in Food, FMCG and Home & Personal Care (HPC) categories. Q3FY25 standalone revenue reached ₹9,103.13 crore, representing a 48.79% year-on-year surge, while nine-month revenue to December 31, 2024 stood at ₹24,430.38 crore.
  • Q3FY25 standalone revenue: ₹9,103.13 crore (+48.79% YoY)
  • 9M FY25 (to Dec 31, 2024) total revenue: ₹24,430.38 crore
  • Q4FY25 Edible Oil sales: ₹6,764.07 crore (+20.90% QoQ/YoY as reported)
  • Composite Food, FMCG & HPC share of operational revenue in Q4FY25: 30.61%
  • Advertising & sales promotion spend in Q4FY25: ~3.36% of revenue
Key segment contributions in the quarter highlight the company's category mix and growth drivers:
  • Food & Other FMCG (Q3FY25): ₹2,037.61 crore
  • Home & Personal Care (HPC) (Q3FY25): ₹420.36 crore
  • Edible Oil (Q4FY25): ₹6,764.07 crore
Metric Period Value (₹ crore) Notes
Standalone Revenue Q3FY25 9,103.13 +48.79% YoY
Total Revenue (9M) Apr-Dec 2024 24,430.38 Aggregate for first nine months of FY25
Food & Other FMCG Q3FY25 2,037.61 Core portfolio expansion
HPC Q3FY25 420.36 Smaller but growing contribution
Edible Oil Sales Q4FY25 6,764.07 +20.90% growth
Composite Food/FMCG/HPC Share Q4FY25 30.61% Share of operational revenue
Ad & Sales Promotion Spend Q4FY25 3.36% of revenue Investment in marketing
  • Diversification: Edible oil remains the dominant revenue engine while Food/FMCG/HPC are scaling and together make nearly one-third of operational sales in Q4FY25.
  • Marketing intensity: ~3.36% of Q4FY25 revenue allocated to advertising and sales promotions underlines a focus on brand building and market share gains.
  • Quarter-to-quarter mix shift: The large edible oil base (₹6,764.07 crore in Q4FY25) cushions the company while newer portfolios grow faster in percentage terms.
For background on the company's origins, strategy and business model, see: Patanjali Foods Limited: History, Ownership, Mission, How It Works & Makes Money

Patanjali Foods Limited (PATANJALI.NS) - Profitability Metrics

Patanjali Foods reported notable improvements in profitability during FY25 quarters, driven by higher operational efficiency and margin expansion across gross, EBITDA and net levels.
  • Q3FY25 EBITDA: ₹581.24 crore - a 48.79% increase year‑on‑year, reflecting stronger core operating performance.
  • Q3FY25 EBITDA margin: 6.39%, indicating improved cost absorption and operational leverage.
  • Q3FY25 Net profit: ₹370.93 crore; Net profit margin: 4.06%.
  • 9M ended Dec 31, 2024 - EBITDA margin: 6.18%; Net profit margin: 3.84%.
  • Q4FY25 Gross profit margin improved by 254 bps to 17.00% (from 14.46% in Q4FY24).
  • Q4FY25 Net profit margin rose by 121 bps to 3.68% (from 2.47% in Q4FY24).
Metric Q4FY24 Q3FY25 Q4FY25 9M FY25 (to Dec 31, 2024)
EBITDA (₹ crore) - 581.24 - -
EBITDA YoY % (Q3) - +48.79% - -
EBITDA Margin - 6.39% - 6.18%
Net Profit (₹ crore) - 370.93 - -
Net Profit Margin 2.47% (Q4FY24) 4.06% (Q3FY25) 3.68% (Q4FY25) 3.84%
Gross Profit Margin 14.46% (Q4FY24) - 17.00% (Q4FY25) -
  • Margin trajectory: Gross margin expansion (254 bps) suggests better input-cost management or favorable product mix in Q4FY25, supporting downstream EBITDA and net margin gains.
  • Quarter vs. 9M: Q3FY25 EBITDA margin (6.39%) slightly above 9M average (6.18%), indicating recent quarters outperformed earlier ones in FY25.
  • Profit conversion: Net margins rising from Q4FY24 through Q3/Q4FY25 highlight improved conversion of gross profit into retained earnings despite industry cost pressures.
For additional context on ownership, buying patterns and investor mix, see: Exploring Patanjali Foods Limited Investor Profile: Who's Buying and Why?

Patanjali Foods Limited (PATANJALI.NS) - Debt vs. Equity Structure

Patanjali Foods Limited reported a debt-free long-term capital structure as of March 2025, with no long-term debt on the balance sheet. Equity (net worth) remains the primary funding source, supported by asset growth and higher working capital.
  • No long-term debt as of 31 March 2025 - implies financial leverage is minimal and interest burden is low.
  • Net worth increased by 10.4% to ₹11,255 crore in FY25 from ₹10,194 crore in FY24.
  • Current liabilities rose 35.6% to ₹4,103 crore in FY25 (₹3,026 crore in FY24), reflecting higher short-term obligations.
  • Current assets increased 21% to ₹9,399 crore in FY25 from ₹7,769 crore in FY24, improving liquidity coverage of short-term liabilities.
  • Fixed assets grew 11.4% to ₹6,017 crore in FY25 from ₹5,402 crore in FY24, indicating continued capex/investment in productive capacity.
Item FY24 (₹ crore) FY25 (₹ crore) Change (%)
Net worth 10,194 11,255 +10.4%
Current assets 7,769 9,399 +21.0%
Current liabilities 3,026 4,103 +35.6%
Fixed assets 5,402 6,017 +11.4%
Total assets & liabilities 13,216 15,420 +17.0%
Long-term debt 0 0 -
Key implications for investors:
  • Equity-centric balance sheet: With net worth of ₹11,255 crore and zero long-term debt, equity absorbs business risk and funds expansion.
  • Working capital dynamics: Current assets of ₹9,399 crore versus current liabilities of ₹4,103 crore provide a current ratio ~2.29x, indicating comfortable near-term liquidity despite the sharp rise in short-term payables.
  • Asset growth supporting scale: Fixed assets and total asset base rising (to ₹6,017 crore and ₹15,420 crore respectively) suggest continued capacity build-out and reinvestment.
  • Leverage profile: Absence of long-term borrowings reduces financial risk but increases reliance on internal accruals and short-term financing for operations and growth.
For context on the company's stated purpose and strategic orientation, see: Mission Statement, Vision, & Core Values (2026) of Patanjali Foods Limited.

Patanjali Foods Limited (PATANJALI.NS) - Liquidity and Solvency

Patanjali Foods Limited's short-term liquidity and long-term solvency metrics for FY25 show a conservative balance-sheet stance with strong cash-generation ability and no reliance on external debt.
  • Current ratio (current assets / current liabilities): 2.29 in FY25 (FY24: 2.57)
  • Quick ratio (current assets excluding inventory / current liabilities): 1.85 in FY25
  • Debt-to-equity ratio: 0.00 in FY25
  • Interest coverage ratio (EBIT / interest expense): 19.5 in FY25
  • Operating cash flow ratio (operating cash flow / current liabilities): 1.15 in FY25 (FY24: 1.05)
  • Solvency ratio (total debt / total assets): 0.00 in FY25
Metric FY24 FY25 Comment
Current Ratio 2.57 2.29 Still comfortably above 1.0; indicates ample working capital
Quick Ratio - 1.85 Strong immediate liquidity excluding inventory
Debt-to-Equity 0.00 0.00 No external debt on the balance sheet
Interest Coverage Ratio - 19.5 High ability to cover interest from operating profits
Operating Cash Flow Ratio 1.05 1.15 Improved cash conversion into operations
Solvency Ratio 0.00 0.00 No reliance on debt financing
  • Implication for investors: strong liquidity cushions, virtually zero financial leverage, and high interest coverage reduce refinancing and default risk while supporting operational flexibility.
  • Watch points: monitor inventory trends (quick ratio vs current ratio gap) and any future shift toward leverage if management pursues aggressive expansion.
Patanjali Foods Limited: History, Ownership, Mission, How It Works & Makes Money

Patanjali Foods Limited (PATANJALI.NS) - Valuation Analysis

Patanjali Foods' valuation metrics as of December 12, 2025, point to a premium multiple relative to peers, driven by market optimism about growth and margin expansion.
  • Stock price: ₹536.85
  • Market capitalization: ₹58,400 crore
  • TTM EPS: ₹13.13
  • TTM P/E: 40.89 (industry average: 24.60)
  • Forward P/E: 35.93
  • Declared dividend: ₹2.42 per share (yield ≈ 0.45%)
  • Analysts' 12‑month average price target: ₹2,000 (implied upside: 236.76%)
Metric Value
Share Price (12‑Dec‑2025) ₹536.85
Market Cap ₹58,400 crore
TTM EPS ₹13.13
TTM P/E 40.89
Industry Avg P/E 24.60
Forward P/E 35.93
Dividend per Share ₹2.42
Dividend Yield ≈ 0.45%
Analyst 12‑Month Target ₹2,000
Implied Upside 236.76%
Key valuation considerations for investors:
  • Premium multiple: TTM P/E (40.89) significantly exceeds the industry average (24.60), indicating market expectations for above‑average earnings growth or superior margin dynamics.
  • Forward P/E compression: The forward P/E (35.93) implies expected EPS growth over the next 12 months, but still represents a premium versus peers.
  • Earnings base and sensitivity: With TTM EPS at ₹13.13, each rupee change in EPS materially shifts implied fair value given the high multiple.
  • Dividend signal: The modest dividend (₹2.42; ~0.45% yield) is not a primary value driver-investors are priced for capital gains rather than income.
  • Analyst optimism and risk: A consensus target of ₹2,000 implies +236.76% upside, which embeds aggressive execution and growth assumptions; downside risk exists if growth or margins disappoint.
Valuation scenarios (simplified):
Scenario Assumed EPS (TTM-adjusted) Applied P/E Implied Price
Base (current EPS) ₹13.13 40.89 ₹536.85
Bear (no EPS growth) ₹13.13 24.60 ₹323.90
Consensus growth (analyst) ₹55.81 35.93 ₹2,005.00
Moderate growth (50% EPS) ₹19.70 30.00 ₹591.00
For further context on shareholding and investor composition that can affect valuation multiples and sentiment, see: Exploring Patanjali Foods Limited Investor Profile: Who's Buying and Why?

Patanjali Foods Limited (PATANJALI.NS) - Risk Factors

Patanjali Foods Limited (PATANJALI.NS) operates in a sector where input-cost dynamics, regulatory shifts and market expansion choices materially influence its financial health. The following outlines the principal risk areas, quantified sensitivities where applicable, and implications for investors.
  • Edible-oil price volatility and input-cost fluctuations
- The edible oil complex has seen year-on-year swings; benchmark crude palm oil and soybean oil prices have moved ±20-40% in volatile periods (example: 2020-2022 commodity swings). For a processor/packer like Patanjali Foods, a sustained 10% rise in oilseed/raw-material costs can compress gross margins by an estimated 150-350 basis points depending on pass-through ability and inventory hedging. - Working-capital pressure: inventory revaluation during sharp price moves can increase working-capital days and cash conversion cycles, straining short-term liquidity.
Metric Illustrative Historical Range Impact on PATANJALI.NS
Crude palm oil / soy oil price change (annual) ±20-40% Gross margin swing: ≈1.5-3.5 ppt per 10% cost move
Inventory days (FMCG edible oil players) 30-90 days Higher days → higher working capital requirement; interest/financing cost rise
Raw material (oilseed) price volatility Seasonal ±15-30% Quarterly EBITDA variability; margin compression in high-cost quarters
  • Integration and competitive risks from Home & Personal Care (HPC) expansion
- Patanjali Foods' strategic move into HPC involves distinct supply chains, regulatory frameworks and brand dynamics versus edible oils/food staples. Integration risks include:
  • Capex and margin dilution in early years - typical FMCG category launches can require 1-3 years to reach scale and 3-7% incremental operating margin drag during rollout.
  • Competition from incumbents (Hindustan Unilever, Dabur, Emami) with distribution and marketing spends often 10-20% of sales versus new entrant benchmarks of 15-30% initially.
- Customer acquisition and channel conflict: balancing traditional Patanjali distribution with modern trade/e-commerce partnerships may raise channel management costs.
  • Fluctuations in specific raw-material prices (oilseeds)
- India's oilseed prices are influenced by monsoon variability and global demand. Example sensitivity:
Scenario Assumed oilseed price change Estimated EBITDA impact (annual)
Adverse (poor crop) +25% EBITDA decline: ≈15-25% (company-specific)
Normal ±5% Minor EBITDA fluctuations: ≈±3-6%
Favorable (surplus) -15% EBITDA improvement: ≈10-18%
  • Regulatory and compliance risk in FMCG
- Regulatory changes (food safety norms, labeling, advertising rules, environmental/packaging regulations) can increase compliance costs. Example impacts:
  • New packaging/extended producer responsibility rules could raise per-unit packaging costs by ₹0.50-₹2.00 depending on SKU and scale.
  • Stricter food-safety testing and documentation may increase overhead and slow time-to-market for new SKUs.
  • Concentration on domestic markets and regional economic exposure
- Patanjali Foods derives a large portion of revenue from India; regional downturns, state-level policy shifts (e.g., pricing control, farm-gate procurement rules) can disproportionately affect local sales and margins. - A localized decline of 5-10% in discretionary fast-moving categories in a major state can translate into a 2-4% hit to consolidated revenue, depending on geographic revenue concentration.
  • Currency exchange rate fluctuations and export exposure
- While largely domestic, any export revenue or imported inputs (additives, packaging materials) expose the company to FX risk. Example:
Exposure type Exchange movement Impact
Exports (USD revenue) INR appreciation 5-10% Revenue in INR down 5-10% unless priced in local currency or hedged
Imported packaging/raw materials INR depreciation 5-10% Input cost increase; margin pressure if not passed on
  • Financial and leverage considerations
- High working-capital cycles from commodity-driven businesses can necessitate short-term borrowings. Typical stress indicators:
  • Rising gross debt-to-equity or elevated interest coverage volatility during commodity spikes.
  • Quarterly cash-flow swings requiring temporary fund raises or higher-cost credit.
  • Mitigation and monitoring metrics for investors
- Investors should track:
  • Quarterly gross margin and raw-material cost per MT trends
  • Working-capital days and debt maturity profile
  • HPC segment revenue mix, marketing spend as % of sales, and channel KPIs
  • Disclosure on hedging policies for commodity and FX exposure
Exploring Patanjali Foods Limited Investor Profile: Who's Buying and Why?

Patanjali Foods Limited (PATANJALI.NS) - Growth Opportunities

Patanjali Foods Limited is positioning itself to capture growth across FMCG, nutraceuticals, exports and vertical integration through raw material control. Key strategic moves undertaken in 2024-25 provide measurable levers for revenue and margin expansion.
  • Acquisition: Purchase of the Home & Personal Care business in November 2024 to enter a high-frequency FMCG category and leverage distribution synergies.
  • Exports: International expansion with export revenues of ₹73.44 crore in Q4FY25, signaling initial traction outside India.
  • Nutraceuticals: Quarterly nutraceuticals sales of ₹19.42 crore point to growing demand in health-focused product lines.
  • Brand & Marketing: Advertising spend surged from ₹71.45 crore in FY24 to ₹233.36 crore in FY25 to support brand-building and market-share gains.
  • Vertical Integration: Development of oil palm plantations spanning 87,109 hectares aimed at increasing self-sufficiency in edible oil raw materials.
  • Distribution & Rural Penetration: Continued emphasis on expanding distribution reach and rural market penetration to unlock untapped demand.
Metric Value Period
Home & Personal Care Acquisition Completed November 2024
Export Revenue ₹73.44 crore Q4 FY25
Nutraceuticals Quarterly Sales ₹19.42 crore Q4 FY25
Advertising Expenditure ₹71.45 crore → ₹233.36 crore FY24 → FY25
Oil Palm Plantations 87,109 hectares As reported FY25
Patanjali's growth pathway rests on converting these investments into sustained top-line momentum and improved gross margins via raw material self-sufficiency and cross-category brand leverage. For more context on shareholder composition and who's buying, see: Exploring Patanjali Foods Limited Investor Profile: Who's Buying and Why?

DCF model

Patanjali Foods Limited (PATANJALI.NS) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.